Medicare Enrolled
Dr. Vivek Bansal, M.D., MPH, FACE
Endocrinology · Edison, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bansal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bansal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bansal
Dr. Vivek Bansal is an endocrinology specialist in Edison, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Bansal performed 953 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bansal received a total of $50,442 from 71 pharmaceutical and/or device companies across 729 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bansal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 46% volume in NJ
$50,442 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗953
Medicare services
Top 46% in NJ for endocrinology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
518 | $105 | $246 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
158 | $29 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
142 | $139 | $369 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
72 | $28 | $59 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
19 | $113 | $303 |
| Annual depression screening | 19 | $18 | $42 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
14 | $75 | $205 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
11 | $103 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$50,442
Total received (2018-2024)
Avg $7,206/year across 7 years
Top 8% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
729
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$28,364
2023
$11,159
2022
$1,442
2021
$6,758
2020
$1,375
2019
$853
2018
$492
Payments by company (2024)
Abbott Laboratories
$20,124
CeQur Corporation
$6,078
Lilly USA, LLC
$481
Novo Nordisk Inc
$255
Corcept Therapeutics
$203
Boehringer Ingelheim Pharmaceuticals, Inc.
$162
Xeris Pharmaceuticals, Inc.
$155
SANOFI-AVENTIS U.S. LLC
$116
Dexcom, Inc.
$100
Amneal Pharmaceuticals LLC
$83
Mannkind Corporation
$77
Medtronic, Inc.
$63
Madrigal Pharmaceuticals
$56
Bayer Healthcare Pharmaceuticals Inc.
$50
Insulet Corporation
$50
VIVUS LLC
$49
Kyowa Kirin, Inc.
$46
Amgen Inc.
$30
Averitas Pharma Inc.
$26
Tandem Diabetes Care, Inc.
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Amphastar Pharmaceuticals, Inc.
$16
Embecta Corp.
$16
Boston Scientific Corporation
$15
Rhythm Pharmaceuticals, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Neurocrine Biosciences, Inc.
$14
PFIZER INC.
$14
Novartis Pharmaceuticals Corporation
$13
Top 3 companies account for 94.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$21,991
Bayer Healthcare Pharmaceuticals Inc.
$7,473
CeQur Corporation
$6,231
GRT US Holding, Inc.
$5,149
Novo Nordisk Inc
$1,623
Lilly USA, LLC
$1,232
SANOFI-AVENTIS U.S. LLC
$762
Boehringer Ingelheim Pharmaceuticals, Inc.
$511
AstraZeneca Pharmaceuticals LP
$506
Dexcom, Inc.
$408
Xeris Pharmaceuticals, Inc.
$355
MannKind Corporation
$328
Corcept Therapeutics
$297
Mannkind Corporation
$269
Amgen Inc.
$266
Bayer HealthCare Pharmaceuticals Inc.
$203
Insulet Corporation
$187
Medtronic, Inc.
$176
Merck Sharp & Dohme Corporation
$160
VIVUS LLC
$157
Amneal Pharmaceuticals LLC
$141
E.R. Squibb & Sons, L.L.C.
$135
IBSA Pharma Inc.
$89
PFIZER INC.
$84
LifeScan, Inc.
$79
Eisai Inc.
$79
DEXCOM, INC.
$78
Amarin Pharma Inc.
$73
GENZYME CORPORATION
$72
Shire North American Group Inc
$70
Kyowa Kirin, Inc.
$61
Boston Scientific Corporation
$59
Madrigal Pharmaceuticals
$56
Averitas Pharma Inc.
$55
Janssen Pharmaceuticals, Inc
$55
AbbVie Inc.
$54
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$50
RGH Enterprises LLC
$47
Echosens North America, Inc.
$45
Tandem Diabetes Care, Inc.
$45
Alexion Pharmaceuticals, Inc.
$45
Novartis Pharmaceuticals Corporation
$44
AbbVie, Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$39
Kowa Pharmaceuticals America, Inc.
$39
Becton, Dickinson and Company
$32
Horizon Therapeutics plc
$31
Regeneron Healthcare Solutions, Inc.
$30
Amphastar Pharmaceuticals, Inc.
$30
Allergan, Inc.
$29
Currax Pharmaceuticals LLC
$29
Zealand Pharma US, Inc.
$27
INTRA-SANA LABORATORIES
$26
Endo Pharmaceuticals Inc.
$26
Valeritas, Inc.
$26
Companion Medical, Inc.
$23
Astellas Pharma US Inc
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Tolmar, Inc.
$17
Embecta Corp.
$16
Rhythm Pharmaceuticals, Inc.
$15
VIVUS, Inc.
$15
Antares Pharma, Inc.
$15
Ipsen Biopharmaceuticals, Inc
$14
Neurocrine Biosciences, Inc.
$14
Intra-Sana Laboratories
$14
ABBVIE INC.
$13
Medtronic MiniMed, Inc.
$13
Althera Pharmaceuticals LLC
$12
Amryt Pharma Holdings Ltd
$12
Clarus Therapeutics Inc.
$7
Top 3 companies account for 70.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · BD ULTRA-FINE · BD Ultra-Fine · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · IMCIVREE · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · Lenvima · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MULTAQ · MYCAPSSA · Macrilen · Minimed 670G System · Minimed 770G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NATRELLE SALINE-FILLED BREAST IMPLANTS · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PANCREAZE · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · QUTENZA · Qsymia · Qutenza · RECORLEV · RELTONE 200 MG · RESMETIROM · REZDIFFRA · RYBELSUS · Repatha · Roszet · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRIJARDY XR · TRULICITY · TZIELD · Tirosint · Tresiba · UNITHROID · V-GO · Varithena Administration Pack · Vascepa · Veozah · Victoza · Wegovy · XARELTO · ZEGALOGUE · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
366
County median income
$109,028
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bansal is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bansal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bansal performed 518 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bansal receive payments from pharmaceutical companies?
Yes. Dr. Bansal received a total of $50,442 from 71 companies across 729 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bansal's costs compare to other endocrinologists in Edison?
Dr. Bansal's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bansal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Edison
Browse endocrinologists in Edison ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NJ
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NJ
Which NJ endocrinologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
By company
CeQur Corporation Payments to Doctors
See all physicians who received payments from CeQur Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology